Premium
Trends in the risk of second primary cancer among bladder cancer survivors: a population‐based cohort of 10 047 patients
Author(s) -
Muller Joris,
Grosclaude Pascale,
LapôtreLedoux Bénédicte,
Woronoff AnneSophie,
Guizard AnneValérie,
Bara Simona,
Colonna Marc,
Troussard Xavier,
Bouvier Véronique,
Trétarre Brigitte,
Velten Michel,
Jégu Jérémie
Publication year - 2016
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.13351
Subject(s) - medicine , bladder cancer , poisson regression , confidence interval , lung cancer , incidence (geometry) , population , cohort , cancer , prostate cancer , cancer registry , relative risk , multivariate analysis , oncology , physics , environmental health , optics
Objectives To determine whether the risk of second primary cancer ( SPC ) among patients with bladder cancer ( BC a) has changed over past years. Materials and Methods Data from 10 French population‐based cancer registries were used to establish a cohort of 10 047 patients diagnosed with a first invasive (≥T1) BC a between 1989 and 2004 and followed up until 2007. An SPC was defined as the first subsequent primary cancer occurring at least 2 months after a BC a diagnosis. Standardized incidence ratios ( SIR s) of metachronous SPC were calculated. Multivariate Poisson regression models were used to assess the direct effect of the year of BC a diagnosis on the risk of SPC . Results The risk of new malignancy among BC a survivors was 60% higher than in the general population ( SIR 1.60, 95% confidence interval [ CI ] 1.51–1.68). Male patients presented a high risk of SPC of the lung ( SIR 3.12), head and neck ( SIR 2.19) and prostate ( SIR 1.54). In multivariate analyses adjusted for gender, age at diagnosis and follow‐up, a significant increase in the risk of SPC of the lung was observed over the calendar year of BC a diagnosis ( P for linear trend 0.010), with an SIR increasing by 3.7% for each year (95% CI 0.9–6.6%); however, no particular trend was observed regarding the risk of SPC of the head and neck ( P = 0.596) or the prostate ( P = 0.518). Conclusions As the risk of SPC of the lung increased between 1989 and 2004, this study contributes more evidence to support the promotion of tobacco smoking cessation interventions among patients with BC a.